Hindié, E. (2020). Metastatic melanoma: Can FDG-PET predict success of anti-PD-1 therapy and help determine when it can be discontinued? European journal of nuclear medicine and molecular imaging, 47(10), 2227-2232. https://doi.org/10.1007/s00259-020-04826-7
Citace podle Chicago (17th ed.)Hindié, Elif. "Metastatic Melanoma: Can FDG-PET Predict Success of Anti-PD-1 Therapy and Help Determine When It Can Be Discontinued?" European Journal of Nuclear Medicine and Molecular Imaging 47, no. 10 (2020): 2227-2232. https://doi.org/10.1007/s00259-020-04826-7.
Citace podle MLA (9th ed.)Hindié, Elif. "Metastatic Melanoma: Can FDG-PET Predict Success of Anti-PD-1 Therapy and Help Determine When It Can Be Discontinued?" European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 10, 2020, pp. 2227-2232, https://doi.org/10.1007/s00259-020-04826-7.